<DOC>
	<DOCNO>NCT01948362</DOCNO>
	<brief_summary>To determine safety tolerability single escalating dos Sulforadex® healthy male volunteer .</brief_summary>
	<brief_title>Sulforadex Healthy Volunteers SAD</brief_title>
	<detailed_description>This study conduct randomise , double-blind , placebo-controlled design single ascending dos Sulforadex® administer healthy male subject 18 45 year age . Each healthy subject receive verbal write information follow signing Informed Consent Form ( ICF ) . Subjects screen within 21 day prior admission . At visit medical examination perform assess eligibility healthy subject . Screening conducted 1 day may divide 1 day . The first cohort study commence one sentinel group . The subsequent group may dose together without sentinel dosing . The study expect 5 cohort total 29 healthy male subject :</detailed_description>
	<criteria>1 . Healthy male subject age 18 45 year ( inclusive ) screening . 2 . Had Body Mass Index ( BMI ) 18.5 25.0 kg/m2 ( inclusive ) screening . 3 . Subjects agree use acceptable method contraception 1 . Subjects could refrain eat brassica vegetable use brassica contain supplement least 7 day prior drug administration . 2 . History clinical evidence clinically significant disease condition disease affect drug absorption , distribution excretion . 3 . Any history clinically significant abnormal laboratory , vital sign safety finding determine medical history , physical examination evaluation conduct screen admission . 4 . Electrocardiogram ( ECG ) abnormalities standard 12lead ECG ( screen Day 1 ) 24hour 5lead Holter ECG ( screen ) opinion Investigator interfere ECG analysis . 5 . Any history current evidence clinically relevant cardiovascular , pulmonary , hepatic , renal , gastrointestinal , haematological , endocrinological , metabolic , neurological psychiatric disease . 6 . Positive screen Hepatitis B ( Hepatitis B surface Antigen , HBsAG ) , Hepatitis C ( Hepatitis C Antibody , antiHCV ) HIV . 7 . Confirmed positive result urine drug screen screen admission ( Day 1 ) indicate drug abuse include : amphetamine , benzodiazepine , cocaine , cannabinoids , opiate , barbiturate , tricyclic antidepressant methadone confirm positive alcohol breath test screen admission ( Day 1 ) . 8 . History clinical evidence alcoholism drug abuse . Alcohol abuse define regular weekly intake 14 unit female 21 unit male ( Using alcohol tracker http : //www.nhs.uk/Tools/Pages/NHSAlcoholtracker.aspx ) ; drug abuse define compulsive , repetitive and/or chronic use drug substance without problem relate use and/or stop reduction dose lead withdrawal symptom . 9 . Subject mentally handicap . 10 . Participation another drug trial within 90 day prior first drug administration . 11 . Use medication ( include overthecounter [ OTC ] medication ) within 2 week prior admission ( Day 1 ) within 10 time elimination halflife respective drug anticipate concomitant medication treatment period . Limited amount paracetamol allow treat AEs . 12 . Subjects donate 500 mL blood within 90 day prior drug administration . 13 . Smoking 10 cigarette equivalent amount tobacco per day subject could stop smoke duration study whilst CPU . 14 . Treatment herbal sulforaphane contain supplement 7 day prior dose , use vitamin 48 hour prior admission ( Day 1 ) . 15 . Any circumstance condition ( ) opinion Investigator would compromise full participation trial compliance protocol . 16 . Subjects legal incapacity limited legal capacity screening . 17 . Subjects vegetarian , vegan medical dietary restriction .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>